Dr. Glaser was a founding member of the Invenra scientific team and was the Vice President of
Research responsible for overseeing the development of its B-Body™ multispecific technologies
as well as early discovery efforts for internal and partnered programs in immuno-oncology. Dr.
Glaser is now Vice President of Business Development, responsible for leading efforts in
partnering Invenra pipeline assets as well as establishing new strategic collaborations. Dr.
Glaser received his Ph.D. in Molecular and Cellular Pharmacology from the University of
Wisconsin and was a postdoctoral fellow/Senior Scientist at the non-profit, SRI International.